Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC II Acquisition | ASCB | Nov 20, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Nov 20, 2024 | 30.83 | +2.46 |
a.k.a Brands | AKA | Nov 20, 2024 | 18.75 | -1.32 |
A.O Smith | AOS | Nov 20, 2024 | 71.75 | +0.48 |
A10 Networks | ATEN | Nov 20, 2024 | 16.48 | +0.49 |
A2Z Cust2Mate Solutions | AZ | Nov 20, 2024 | 6.44 | -3.16 |
AA Mission Acquisition | AAM | Nov 20, 2024 | 10.05 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | Nov 20, 2024 | 47.37 | -0.25 |
Aadi Bioscience | AADI | Nov 20, 2024 | 2.22 | +0.45 |
AAON | AAON | Nov 20, 2024 | 132.05 | +0.68 |
AAR | AIR | Nov 20, 2024 | 67.54 | +0.28 |
Abacus Life | ABL | Nov 20, 2024 | 8.86 | +5.10 |
Abbott Laboratories | ABT | Nov 20, 2024 | 115.93 | -1.02 |
AbbVie | ABBV | Nov 20, 2024 | 167.76 | +0.71 |
AbCellera Biologics | ABCL | Nov 20, 2024 | 2.67 | -1.48 |
Abeona Therapeutics | ABEO | Nov 20, 2024 | 5.75 | -2.38 |
Abercrombie & Fitch | ANF | Nov 20, 2024 | 136.81 | -4.05 |
Aberdeen Asia-Pacificome Fund | FAX | Nov 20, 2024 | 15.92 | +0.06 |
Aberdeen Australia Equity Fund | IAF | Nov 20, 2024 | 4.59 | -0.22 |
Aberdeen Emerging Markets Fund | AEF | Nov 20, 2024 | 5.22 | -0.38 |
Aberdeen Global Fund | FCO | Nov 20, 2024 | 6.01 | +0.53 |
Aberdeen Global Infrastructure | ASGI | Nov 20, 2024 | 19.77 | +0.76 |
Aberdeen Income Credit Strategies Fund | ACP | Nov 20, 2024 | 6.52 | 0.00 |
Aberdeen Income Credit Strategies Pref | ACP-A | Nov 20, 2024 | 23.01 | -1.10 |
Aberdeen Japan Equity Fund | JEQ | Nov 20, 2024 | 5.73 | -1.21 |
Abits Group | ABTS | Nov 20, 2024 | 0.62 | +10.11 |
Abivax SA - American Depositary Shares | ABVX | Nov 20, 2024 | 8.86 | -0.56 |
Able View Global | ABLV | Nov 20, 2024 | 0.86 | -0.01 |
ABM Industries | ABM | Nov 20, 2024 | 55.58 | +0.40 |
Above Food Ingredients | ABVE | Nov 20, 2024 | 0.67 | +17.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.